Get the Stockscreener App
176.01
2.58%
-4.67
After Hours:
176.01
Davita Inc stock is traded at $176.01, with a volume of 573.90K.
It is down -2.58% in the last 24 hours and down -26.70% over the past month.
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$180.68
Open:
$179.74
24h Volume:
573.90K
Relative Volume:
0.68
Market Cap:
$11.23B
Revenue:
$13.84B
Net Income/Loss:
$1.10B
P/E Ratio:
16.89
EPS:
10.4185
Net Cash Flow:
$1.49B
1W Performance:
-0.28%
1M Performance:
-26.70%
6M Performance:
+12.61%
1Y Performance:
+27.77%
1-Day Range:
$175.71
$180.35
1-Week Range:
$173.37
$182.53
52-Week Range:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
176.01 | 11.18B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
414.45 | 87.96B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
265.91 | 21.95B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.74 | 12.47B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
120.21 | 11.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
DaVita dialysis clinic in Novi has repeated deficiencies as families demand answers after 2 deaths - WXYZ Channel 7
Wealthfront Advisers LLC Buys Shares of 10,596 DaVita Inc. $DVA - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA - MarketBeat
Danske Bank A S Invests $13.11 Million in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Thursday when compared to competitors - MarketWatch
DaVita stock steadies after Q2 revenue growth but EPS outlook disappoints - Ad-hoc-news.de
Patients Share Their Experiences With Expanded HD - DaVita Newsroom
DaVita (DVA) Financial Results: EPS Exceeds Its Estimate on the Day; Market Response: The Stock Loses 0.36%Strong Earnings Momentum - Vinanet
DaVita stock slips after Q2 revenue beats forecasts - Ad-hoc-news.de
DaVita (NYSE: DVA) reports new insider stock trade - Stock Titan
DaVita (NYSE: DVA) director Phyllis Yale gets 278-share stock award - Stock Titan
DaVita (NYSE: DVA) insider logs new stock trade in SEC filing - Stock Titan
DaVita (NYSE: DVA) director now holds 5,970 shares after award - Stock Titan
Forever Committed to Excellence in Care: DaVita Community Care Report 2025 - CSRwire
News by ACCESS Newswire on TradingView, 2026-08-18 - TradingView
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Analysis: A Strong ROE And 21% Potential Upside - DirectorsTalk Interviews
Enterprise value to revenue forward of DaVita Inc. – BX:TRL - TradingView
Stronger Q2 Earnings and Transplant Focus Might Change The Case For Investing In DaVita (DVA) - simplywall.st
Bank of America Corp DE Cuts Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Community Care Report 2025: Creating a Culture of Belonging for All - CSRwire
DaVita Inc. $DVA Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Pacer Advisors Inc. Trims Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Empowered Funds LLC - MarketBeat
Are Wall Street Analysts Bullish on DaVita Stock? - webull.com
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. $DVA Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
DaVita Inc. (DVA) Stock Analysis: Strong Upside Potential with an 18.86% Gain on the Horizon - DirectorsTalk Interviews
9,300 Shares in DaVita Inc. $DVA Purchased by Polianta Ltd - MarketBeat
DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat - Yahoo Finance
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story? - webull.com
Why is DaVita stock up 2% today? - Investing.com
DaVita Inc (DVA) Stock News Today - TradingKey
TD Cowen upgrades DaVita stock rating on market position gains - Investing.com
DaVita Shares Rise After TD Cowen Upgrades Stock to Buy - Yahoo Finance
Janus Henderson Group PLC Raises Stock Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc (DVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is DaVita (DVA) a Great Value Stock Right Now? - Yahoo Finance
DaVita Inc. $DVA Shares Bought by California State Teachers Retirement System - MarketBeat
DaVita Inc. (DVA) options chain - Yahoo Finance Australia
SPDR S&P 500(R) Buyback ETF's DaVita Inc(DVA) Holding History - GuruFocus
DaVita Inc (DVA) Shares Fall 17.2% -- GF Value Says Still Overva - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down - Yahoo Finance
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook - StockStory
DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth - The Globe and Mail
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Davita Inc Stock (DVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Waters Kathleen Alyce | Chief Legal & Pub. Affairs Off |
Jun 15 '26 |
Sale |
208.40 |
15,405 |
3,210,377 |
109,194 |
| Rodriguez Javier | Chief Executive Officer |
Jun 16 '26 |
Sale |
209.28 |
39,407 |
8,247,018 |
840,408 |
| Rodriguez Javier | Chief Executive Officer |
Jun 15 '26 |
Sale |
209.50 |
30,000 |
6,285,090 |
879,815 |
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):